1. Pink Sheet
  2. >>Geography
  3. >>Europe

Brexit: UK Joining US-Led Project Orbis To Speed Cancer Drug Approvals

 
• By Neena Brizmohun

Joining the international regulatory collaboration could become a key route for the UK to remain an early and priority market for global launches after the end of the Brexit transition period, says the industry group, BIA.

Alarm clock
The UK is leaving the EU single market and customs union on 1 January 2021 • Source: Shutterstock

In January 2021 the UK will join Project Orbis, the US-led collaborative scheme that enables international regulators to simultaneously review and approve new cancer drugs faster.

The UK medicines agency, the MHRA, will join the scheme fully on 1 January, after the end of the Brexit transition period,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe